Company: BEP
Filing Date: 2025-11-12
Form Type: 424B5
Source: 0001193125-25-275856
Chunk: 12

Company: Brookfield Renewable Partners L.P.
Filing Date: 2025-11-12
Form: 424B5
Chunk 12
---
 a portion of the proceeds of this Offering or the Concurrent Private Placement are not deployed in a timely manner following each respective closing, or if any pending and announced dispositions or acquisitions are not completed on their
anticipated timeframe, or at all, or if the returns from this Offering or any anticipated transactions are lower than the returns we anticipate, the Partnership may not be able to achieve growth in its distributions in line with its stated goals and
the market value of the LP Units may decline. The closing of this Offering is conditional upon the closing of the Concurrent Private Placement and customary closing conditions. This Offering is not conditioned upon the closing of any pending and
announced transaction (other than the Concurrent Private Placement), nor is any pending and announced transaction (other than the Concurrent Private Placement) conditioned upon the closing of this Offering.

For more information see “Where You Can Find More Information” and “Documents Incorporated by Reference” in this
Prospectus Supplement and “Documents Incorporated by Reference” in the Prospectus.

S-3

USE OF PROCEEDS

The estimated net proceeds to the Partnership from this Offering after deducting the Underwriters’ fee and the expenses of this
Offering, estimated at US$1,262,000, will be approximately US$430,738,941 (US$495,539,082 if the Over-Allotment Option is exercised in full), and the proceeds of the Concurrent Private Placement will be approximately US$200,000,000. We intend to use
the net proceeds from this Offering, together with the proceeds of the Concurrent Private Placement, to fund the recently completed acquisition of our increased stake in Isagen, future investment opportunities, and for general corporate purposes.

Management believes we will be able to invest the net proceeds of this Offering and the Concurrent Private Placement within a reasonable
period of time. However, the proceeds of this Offering and the Concurrent Private Placement may not be invested in a timely manner following each respective closing and the returns from such use of proceeds may be lower than the returns we
anticipate. See “Risk Factors”.

S-4

CONSOLIDATED CAPITALIZATION The following table sets forth the consolidated capitalization of the Partnership as at: (a) September 30, 2025 on an actual basis; and (b) September 30, 2025, as adjusted to give effect to this Offering (assuming no exercise of the Over-Allotment Option) and the Concurrent Private Placement as though each had occurred on September 30, 2025,